Stevanato Group S.p.A. (NYSE:STVN) Shares Bought by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. increased its stake in Stevanato Group S.p.A. (NYSE:STVN) by 1,457.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 5,654 shares of the company’s stock after buying an additional 5,291 shares during the period. PNC Financial Services Group Inc.’s holdings in Stevanato Group were worth $123,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of STVN. Marco Investment Management LLC purchased a new position in shares of Stevanato Group in the fourth quarter worth approximately $203,000. Raymond James Financial Inc. acquired a new stake in Stevanato Group during the 4th quarter valued at $5,754,000. M&T Bank Corp purchased a new stake in shares of Stevanato Group in the fourth quarter valued at $572,000. US Bancorp DE boosted its position in shares of Stevanato Group by 17.9% in the fourth quarter. US Bancorp DE now owns 8,527 shares of the company’s stock worth $186,000 after buying an additional 1,295 shares during the period. Finally, Mutual of America Capital Management LLC purchased a new position in shares of Stevanato Group during the fourth quarter valued at $13,848,000.

Stevanato Group Stock Performance

STVN stock opened at €22.34 ($24.02) on Tuesday. The firm has a 50 day moving average of €21.04 and a two-hundred day moving average of €20.59. Stevanato Group S.p.A. has a 12 month low of €16.56 ($17.81) and a 12 month high of €33.49 ($36.01). The company has a market capitalization of $6.77 billion, a price-to-earnings ratio of 47.53, a P/E/G ratio of 7.18 and a beta of 0.60. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. As a group, equities analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Bank of America increased their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Wolfe Research began coverage on shares of Stevanato Group in a research report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. William Blair restated an “outperform” rating on shares of Stevanato Group in a report on Friday, March 7th. Morgan Stanley reiterated an “equal weight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, UBS Group decreased their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Stevanato Group currently has a consensus rating of “Moderate Buy” and an average price target of €27.75 ($29.84).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.